BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

23dihydroxybenzoic Acid

Aromatic Amino Acid Decarboxylase Inhibitors [Pharmacological Action]

81+ PubMed studies analyzed · Evidence Score: 40.5

Research Domains

23dihydroxybenzoic Acid has been studied across 15 research domains including 🧠 Focus & Attention, 🔥 Metabolic, 🔬 Inflammation, 🌤️ Mood & Depression, 🫘 Kidney. The primary research focus is 🧠 Focus & Attention with 9% of studies addressing this area.

Loading evidence profile...

This evidence profile for 23dihydroxybenzoic Acid is generated deterministically from 81 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.